Goldman Sachs Upgrades UnitedHealth Group (UNH) to Conviction Buy Cites Higher Confidence in '14 Earnings Growth
Tweet Send to a Friend
Get Alerts UNH Hot Sheet
Price: $62.36 +0.13%
Rating Summary:
14 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Rating Summary:
14 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 24 | New: 29
Trade UNH Now!
Goldman Sachs upgraded UnitedHealth Group (NYSE: UNH) from Neutral to Conviction Buy with a price target of $66.00 (from $57.00).
The firm cited a favorable view of the 2013 operating outlook along with higher confidence that UNH will grow earnings in 2014. "We expect increased investor visibility on these factors will drive multiple expansion over the next 6-12 months," the analyst said.
While 2013 is important, Goldman believes investor sentiment toward the health reform implementation in 2014 and beyond will continue to be the driving factor for managed care stocks.
"For UNH, we see health reform implementation downside risk somewhat more "contained" than we had previously, which is a key factor in our view of the attractive risk-reward profile at current valuation levels," the analyst said.
For an analyst ratings summary and ratings history on UnitedHealth Group click here. For more ratings news on UnitedHealth Group click here.
Shares of UnitedHealth Group closed at $55.75 yesterday, with a 52 week range of $50.32-$60.75.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm cited a favorable view of the 2013 operating outlook along with higher confidence that UNH will grow earnings in 2014. "We expect increased investor visibility on these factors will drive multiple expansion over the next 6-12 months," the analyst said.
While 2013 is important, Goldman believes investor sentiment toward the health reform implementation in 2014 and beyond will continue to be the driving factor for managed care stocks.
"For UNH, we see health reform implementation downside risk somewhat more "contained" than we had previously, which is a key factor in our view of the attractive risk-reward profile at current valuation levels," the analyst said.
For an analyst ratings summary and ratings history on UnitedHealth Group click here. For more ratings news on UnitedHealth Group click here.
Shares of UnitedHealth Group closed at $55.75 yesterday, with a 52 week range of $50.32-$60.75.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard (HPQ) Q2 Performance Wins Praise on Wall Street; Jefferies Raises to Hold
- Deutsche Bank Adjusts Dean Foods (DF) Price Target to $13
- Toll Bros. (TOL) Q2 Solid but Not Much Better Than Peers
Create E-mail Alert Related Categories
Analyst PT Change, Hot Upgrades, UpgradesRelated Entities
Goldman Sachs Conviction Buy List, Goldman Sachs, Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
